Teva Pharmaceutical Industries Limited (TLV:TEVA)

Market Cap	122.76B +115.8%
Revenue (ttm)	54.78B +4.4%
Net Income	4.94B
EPS	4.23
Shares Out	n/a
PE Ratio	24.84
Forward PE	14.62
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	1,144,074
Open	10,510
Previous Close	10,360
Day's Range	10,410 - 10,690
52-Week Range	5,305 - 11,350
Beta	0.76
RSI	64.05
Earnings Date	Apr 29, 2026

About TLV:TEVA

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The com...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1901
• Employees: 32,842
• Stock Exchange: Tel Aviv Stock Exchange
• Ticker Symbol: TEVA

Financial Performance

Financial numbers in USD